Improving biomarker identification with better designs and reporting.
作者信息
Pepe Margaret S, Feng Ziding
机构信息
Biostatistics and Biomathematics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
出版信息
Clin Chem. 2011 Aug;57(8):1093-5. doi: 10.1373/clinchem.2011.164657.
Abstract
摘要
相似文献
1
Improving biomarker identification with better designs and reporting.通过更好的设计和报告来改进生物标志物的识别。
Clin Chem. 2011 Aug;57(8):1093-5. doi: 10.1373/clinchem.2011.164657.
2
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.多发性硬化症中的抗髓鞘少突胶质细胞糖蛋白抗体
Neurology. 2004 Jun 8;62(11):1922-3. doi: 10.1212/01.wnl.0000130069.55343.06.
3
The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.髓鞘少突胶质细胞糖蛋白（MOG）：实验性自身免疫性脑脊髓炎和多发性硬化中抗体介导的脱髓鞘模型。
J Neural Transm Suppl. 2000(58):123-33. doi: 10.1007/978-3-7091-6284-2_10.
4
Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice.
Biochem Soc Trans. 1997 May;25(2):168S. doi: 10.1042/bst025168s.
5
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.针对天然髓鞘少突胶质细胞糖蛋白的抗体是多发性硬化症早期炎症的血清学标志物。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2280-5. doi: 10.1073/pnas.0510672103. Epub 2006 Feb 3.
6
Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions.髓鞘少突胶质细胞糖蛋白诱导的普通狨猴实验性自身免疫性脑脊髓炎反映了II型多发性硬化病变的免疫病理学特征。
Mult Scler. 2006 Aug;12(4):369-74. doi: 10.1191/1352458506ms1290oa.
7
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.实验性自身免疫性脑脊髓炎和多发性硬化中T细胞和B细胞对髓鞘少突胶质细胞糖蛋白的反应
Glia. 2001 Nov;36(2):220-34. doi: 10.1002/glia.1111.
8
Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.用髓鞘少突胶质细胞糖蛋白的免疫显性表位在小鼠中诱导多发性硬化样疾病。
Autoimmunity. 1998;28(2):109-20. doi: 10.3109/08916939809003872.
9
Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.多反应性髓鞘少突胶质细胞糖蛋白抗体：对进行性实验性自身免疫性脑脊髓炎中全身自身免疫的影响。
J Neuroimmunol. 2007 Feb;183(1-2):69-80. doi: 10.1016/j.jneuroim.2006.11.024. Epub 2007 Jan 2.
10
Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.多发性硬化及其动物模型实验性自身免疫性脑脊髓炎中的体液免疫
Immunol Res. 2005;32(1-3):85-97. doi: 10.1385/IR:32:1-3:085.
引用本文的文献
1
HES V2.0 surpasses GALAD for HCC detection: a review of multi-dimensional biomarker scores and studies.HES V2.0在肝癌检测方面超越GALAD：多维生物标志物评分及研究综述
Hepat Oncol. 2025 Dec;12(1):2494446. doi: 10.1080/20450923.2025.2494446. Epub 2025 Apr 30.
2
Are Non-invasive Multi-cancer Early Cancer Detection Tests the Future?非侵入性多癌早期癌症检测测试是未来的发展方向吗？
Dig Dis Sci. 2025 Jan 30. doi: 10.1007/s10620-024-08839-2.
3
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies.胰腺癌的早期检测：生物标志物发现及早期验证研究中的研究设计与分析考量
Pancreatology. 2024 Dec;24(8):1265-1279. doi: 10.1016/j.pan.2024.10.012. Epub 2024 Oct 29.
4
MRI Radiomics in Imaging of Focal Hepatic Lesions: A Narrative Review.肝脏局灶性病变成像中的MRI影像组学：叙述性综述
Cureus. 2024 Jun 17;16(6):e62570. doi: 10.7759/cureus.62570. eCollection 2024 Jun.
5
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States.在检测肝癌方面，HES V2.0优于GALAD：美国一项3期生物标志物研究。
Hepatology. 2025 Feb 1;81(2):465-475. doi: 10.1097/HEP.0000000000000953. Epub 2024 Jun 19.
6
Identification of Exo-miRNAs: A Summary of the Efforts in Translational Studies Involving Triple-Negative Breast Cancer.外泌体 miRNA 的鉴定：三阴性乳腺癌相关转化研究的综述。
Cells. 2023 May 7;12(9):1339. doi: 10.3390/cells12091339.
7
CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII.放射组学研究评估清单（CLEAR）：由欧洲放射学会（ESR）和欧洲医学影像信息学会（EuSoMII）认可的作者和审稿人分步报告指南。
Insights Imaging. 2023 May 4;14(1):75. doi: 10.1186/s13244-023-01415-8.
8
Biomarkers of Chronic Pancreatitis: A systematic literature review.慢性胰腺炎的生物标志物：系统文献综述。
Pancreatology. 2021 Mar;21(2):323-333. doi: 10.1016/j.pan.2021.01.006. Epub 2021 Jan 22.
9
Multi-view based integrative analysis of gene expression data for identifying biomarkers.基于多视图的基因表达数据综合分析鉴定生物标志物。
Sci Rep. 2019 Sep 18;9(1):13504. doi: 10.1038/s41598-019-49967-4.
10
Clinical significance and biological roles of cyclins in gastric cancer.细胞周期蛋白在胃癌中的临床意义及生物学作用
Onco Targets Ther. 2018 Oct 9;11:6673-6685. doi: 10.2147/OTT.S171716. eCollection 2018.
本文引用的文献
1
Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening.通过组合文库筛选鉴定阿尔茨海默病的候选 IgG 生物标志物。
Cell. 2011 Jan 7;144(1):132-42. doi: 10.1016/j.cell.2010.11.054.
2
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.用于分类或预测的生物标志物准确性的关键评估：研究设计标准
J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8. doi: 10.1093/jnci/djn326. Epub 2008 Oct 7.
3
Reporting recommendations for tumor marker prognostic studies.肿瘤标志物预后研究的报告建议
J Clin Oncol. 2005 Dec 20;23(36):9067-72. doi: 10.1200/JCO.2004.01.0454. Epub 2005 Sep 19.
4
Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective.基因组和蛋白质组生物标志物发现与验证的研究问题及策略：统计学视角
Pharmacogenomics. 2004 Sep;5(6):709-19. doi: 10.1517/14622416.5.6.709.
5
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.用于报告诊断准确性研究的STARD声明：解释与详述
Clin Chem. 2003 Jan;49(1):7-18. doi: 10.1373/49.1.7.
Zotero 插件